Karen Cheng

Karen Cheng

Patient Advocate International Myositis Society
Karen Cheng

Karen is a global healthcare executive with a passion for advancing patient care in rare diseases. With a medical background and international experience in medical affairs, clinical development, patient engagement, and commercialisation of medical devices and pharmaceuticals, she has led international product launches and cross-functional initiatives across multiple disease areas. Karen’s work in the industry is inspired by her unique journey as a rare disease patient, which fuels her dedication and deep commitment to advancing patient care and outcomes through innovation, advocacy, education and global health strategies.

Pharma Launch Excellence Summit Pre-Conference Focus Day: Launch Excellence in Rare Disease: Tuesday 1st December

10:40 AM Panel Discussion: Partnering with Patient Advocacy Groups in Drug Development to Accelerate Rare Disease Launch Success

Patient advocacy groups can play a pivotal role in the successful development and launch of rare disease therapies. Early collaboration with patient advocacy groups can be a critical determinant of launch success. How can launch excellence teams ensure patient perspectives are meaningfully embedded throughout the drug development lifecycle?
• Building strong relationships with patients, caregivers, patient advocacy groups and external experts to maximise the success of your rare disease therapy launch
• Leveraging patient advocacy group partnerships to gain critical insights, engage diverse patient populations and support market access efforts to ensure your therapy successfully reaches patients who need it most
• Discovering how successful rare disease launches benefited from strong collaboration with patient advocacy groups to apply lessons learned to your next launch

Check out the incredible speaker line-up to see who will be joining Karen.

Download The Latest Agenda